Multimeric-001 Influenza Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Multimeric-001 Influenza Vaccine, covering 2016-02-23 to 2016-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV [Phase 2]